Name: CJC-1295 (No DAC) 5 mg
Brand: Peptide Revolution
SKU: 8734
Price: 36.4 EUR
Availability: BackOrder
Rating: 5 (1 reviews)

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Product Description

Research Peptide · GHRH Analog

CJC-1295 (No DAC) 5 mg

Research-grade lyophilized powder supplied in a sealed glass vial. Each vial contains CJC-1295 (No DAC) 5 mg, a synthetic analogue of growth hormone-releasing hormone (GHRH), also known as Modified GRF (1-29), studied in controlled experimental models of pituitary signaling, growth-hormone release, and GHRH-receptor agonism.

Research Use Only

This product is intended strictly for laboratory and scientific investigation. Not for human consumption, therapeutic use, or veterinary application.

Specifications

Purity

High-purity research grade

Form

Lyophilized powder

Also Known As

Modified GRF (1-29) / Mod GRF 1-29

Content

CJC-1295 (No DAC) 5 mg per vial

Packaging

Sealed glass vial with sterile stopper

Storage

Store desiccated at 2–8 °C, protected from light

Molecular Formula

C152H252N44O42

Molecular Weight

≈ 3367.9 g/mol

CAS Number

863288-34-0

Reconstitution

In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC), supporting controlled preparation and research-only handling procedures.

For a compatible research-only solvent, see Bacteriostatic Water – 10 ml.

Research Overview

CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic analogue of growth hormone-releasing hormone studied in metabolic and endocrine research. It is investigated for its agonist activity at the GHRH receptor and its influence on the amplitude and frequency of pituitary growth-hormone pulses. Without the Drug Affinity Complex (DAC), it exhibits a short circulating half-life, making it a common tool for studying pulsatile GH-release patterns in controlled experimental settings. No therapeutic or clinical claims are made or implied.